AMSTERDAM – Belgian pharmaceutical compounding giant Fagron NV announced on Friday two strategic acquisitions to expand its presence in Asia-Pacific and Brazil, coupled with a crucial regulatory license in the United States, marking a significant step in its global growth strategy. The company said it has acquired Amber Compounding Pharmacy, a leader in Singapore and…
BRUSSELS: Belgian pharmaceutical compounding firm Fagron said on Monday it had acquired the business of Poland’s Amara and Hungary’s Magilab to strengthen its position in the EMEA region, part of a strategy to diversify in dynamic markets. The company also said it had secured a new $225 million U.S. credit facility and received a…
BRUSSELS: Fagron, a global leader in pharmaceutical compounding, reported a 6.4% increase in third-quarter revenue, reaching €228.2 million, and reaffirmed its full-year guidance amid continued momentum across regions and business lines. Organic growth at constant exchange rates (CER) rose 10.3%, or 8.5% on a normalized basis, with 5.7% growth including the impact of GLP-1-related…